The inextricable link between a high cholesterol diet and colon cancer

Share This Post

In a study of mice, scientists from the University of California, Los Angeles, David Geffen School of Medicine found that raising cholesterol levels in animals caused intestinal stem cells to divide faster, increasing tumor formation by 100 times. This study identified a molecular pathway that could serve as a new drug target for colon cancer treatment.

Cholesterol affects the growth of intestinal stem cells, which in turn accelerates the formation of tumors by more than 100 times. Although the link between cholesterol in the diet and colon cancer has been established, no one has previously explained the mechanism behind it. Scientists increased cholesterol in some intestinal stem cells of mice by introducing more substances into the diet. In another study, the researchers changed a gene that regulates phospholipids, which are the main type of fat in cell membranes, prompting cells to produce more cholesterol themselves.

Stem cells have increased reproductive capacity in both groups. As cholesterol levels increase, their cells divide more rapidly, making the intestines longer, and these changes significantly accelerate the rate of tumor formation in the colon.

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

Risk of developing secondary tumors following CAR-T cell therapy is minimal - A Stanford Study
CAR T-Cell therapy

Risk of developing secondary tumors following CAR-T cell therapy is minimal – A Stanford Study

CAR-T cell therapy, a groundbreaking cancer treatment, carries a risk of developing secondary tumors. This occurs due to the therapy’s potential to cause genetic mutations or alter the immune system’s regulation. Secondary malignancies can arise from these changes, presenting a significant long-term risk for patients. Continuous monitoring and research are crucial to understanding and mitigating these risks, ensuring safer outcomes for those undergoing CAR-T cell therapy.

Seattle Children's Hospital to Start CAR T-Cell Clinical Trial for Pediatric Lupus Patients
CAR T-Cell therapy

Seattle Children’s Hospital to Start CAR T-Cell Clinical Trial for Pediatric Lupus Patients

Seattle Children’s Hospital is launching a groundbreaking CAR T-cell clinical trial for pediatric lupus patients. This innovative approach harnesses the body’s immune cells to target and eliminate lupus-affected cells, offering new hope for young patients with this autoimmune disorder. The trial represents a significant advancement in lupus treatment, aiming to improve outcomes and reduce long-term complications for children suffering from this challenging condition.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) Cancer treatment abroad?
2) CAR T-Cell therapy
3) Cancer vaccine
4) Online video consultation
5) Proton therapy